SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Finance Ministry notifies concessional rate of GST applicable on COVID relief materials

16 Jun 2021 Evaluate

The Finance Ministry has notified the concessional rate of Goods and Services Tax (GST) that will be applicable on COVID relief materials till September 30, 2021. Also, a lower GST of 5 per cent will be applicable for work contracts for construction, repair or maintenance of electric furnaces meant for funeral, burial or cremation of the deceased. The earlier tax rate of this service was 12 per cent.

The GST Council, chaired by Finance Minister Nirmala Sitharaman and comprising state ministers, on June 12, had slashed tax rate on COVID drugs such as Remdesivir and Tocilizumab as well as on medical oxygen, oxygen concentrators and other COVID essentials. The Finance Ministry’s Revenue Department on June 14, notified the lower rates for 18 COVID-related supplies, like hand sanitiser, pulse oximeters, BiPAP machine, testing kits, ambulances and temperature check equipment. These concessional rates would be applicable till September 30, 2021.

The Council in its June 12 meeting had decided to reduce GST on COVID-19 drug Tocilizumab and black fungus medicine Amphotericin B to ‘nil’, from 5 per cent. The rate on Remdesivir and Anticoagulants like Heparin is lowered from 12 per cent to 5 per cent. The Council also decided to cut the GST rate on ambulances to 12 per cent from 28 per cent.

Tax on medical-grade oxygen, oxygen concentrators (including personal imports), ventilators, BiPAP machines and high flow nasal cannula (HFNC) devices has been reduced to 5 per cent from 12 per cent. Also, tax on COVID testing kits, pulse oximeters (including personal imports) has been brought down to 5 per cent from 12 per cent. Hand sanitisers, temperature check equipment, gas/electric furnaces for crematoriums too will attract a lower 5 per cent tax, from 18 per cent earlier.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: